Covered recipient · General Payments record
MAX L GRATRIX
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,440.19
- Reported across 169 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $653.14 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $255.23 | 16 |
| GENZYME CORPORATION | $110.56 | 4 |
| Lilly USA, LLC | $73.09 | 3 |
| Amgen Inc. | $60.26 | 3 |
| Regeneron Healthcare Solutions, Inc. | $44.88 | 2 |
| Janssen Biotech, Inc. | $31.89 | 2 |
| LEO Pharma Inc. | $22.97 | 1 |
| E.R. Squibb & Sons, L.L.C. | $22.24 | 1 |
| Arcutis Biotherapeutics, Inc. | $16.74 | 1 |
| PFIZER INC. | $13.91 | 1 |
| Biofrontera Inc. | $1.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.58 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829670 | CMS |
| ABBVIE INC. | $26.53 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829672 | CMS |
| ABBVIE INC. | $26.50 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829674 | CMS |
| ABBVIE INC. | $24.06 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829676 | CMS |
| ABBVIE INC. | $11.04 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829678 | CMS |
| ABBVIE INC. | $19.74 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829680 | CMS |
| ABBVIE INC. | $23.11 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829682 | CMS |
| ABBVIE INC. | $7.21 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829684 | CMS |
| ABBVIE INC. | $13.11 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829686 | CMS |
| ABBVIE INC. | $10.91 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829688 | CMS |
| ABBVIE INC. | $7.06 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829690 | CMS |
| ABBVIE INC. | $18.50 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829692 | CMS |
| ABBVIE INC. | $13.48 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829694 | CMS |
| ABBVIE INC. | $16.63 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829696 | CMS |
| ABBVIE INC. | $9.16 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829698 | CMS |
| ABBVIE INC. | $17.61 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103829700 | CMS |
| Amgen Inc. | $21.62 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117265053 | CMS |
| Amgen Inc. | $24.69 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117265055 | CMS |
| Amgen Inc. | $13.95 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117265057 | CMS |
| Arcutis Biotherapeutics, Inc. | $16.74 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121063403 | CMS |
| Biofrontera Inc. | $1.37 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091175823 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.24 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101296705 | CMS |
| GENZYME CORPORATION | $29.09 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139677679 | CMS |
| GENZYME CORPORATION | $21.53 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139677713 | CMS |
| GENZYME CORPORATION | $35.06 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139677733 | CMS |
| GENZYME CORPORATION | $24.88 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139677757 | CMS |
| Janssen Biotech, Inc. | $15.98 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078729412 | CMS |
| Janssen Biotech, Inc. | $15.91 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078729100 | CMS |
| LEO Pharma Inc. | $22.97 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152631865 | CMS |
| Lilly USA, LLC | $23.94 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135179579 | CMS |
| Lilly USA, LLC | $21.03 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135170828 | CMS |
| Lilly USA, LLC | $28.12 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135179577 | CMS |
| PFIZER INC. | $13.91 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132107502 | CMS |
| Regeneron Healthcare Solutions, Inc. | $18.33 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114059302 | CMS |
| Regeneron Healthcare Solutions, Inc. | $26.55 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114059304 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.